Sarepta Therapeutics, Inc. SRPT Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s interest paid?
- Sarepta Therapeutics, Inc. (SRPT) reported interest paid of $23.42M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s interest paid changed year-over-year?
- Sarepta Therapeutics, Inc.'s interest paid increased by 225.8% year-over-year, from $7.19M to $23.42M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s interest paid?
- Over 4 years (2021 to 2025), Sarepta Therapeutics, Inc.'s interest paid has grown at a -28.1% compound annual growth rate (CAGR), from $55.95M to $14.91M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.